Stephen Chia

Evaluation of the clinical benefits of nanoparticle albumin-bound paclitaxel in women with metastatic breast cancer in British Columbia.

S. Chia, C. Speers, A. Lohmann, 2013, Current oncology.

The role of neoadjuvant her2-targeted therapies in her2-overexpressing breast cancers

D. Rayson, L. Provencher, B. Wang, 2009, Current oncology.

Hormone receptor-positive, HER2-negative metastatic breast cancer: redrawing the lines.

S. Verma, S. Chia, A. Joy, 2018, Current oncology.

The role of her2-targeted therapies in women with her2-overexpressing metastatic breast cancer

J. Mackey, S. Verma, M. Clemons, 2009, Current oncology.

Ribociclib plus Endocrine Therapy in Early Breast Cancer.

G. Hortobagyi, D. Yardley, M. Ruíz-Borrego, 2024, The New England journal of medicine.

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer

D. Cescon, B. Surgeoner, J. Boileau, 2024, Current oncology.